October 22, 2013
Imaging with positron emission tomography (PET) scanning has great potential in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research.
The study’s findings were published online September 16, 2013, in the Journal of Clinical Oncology. The multisite trial, led by study author and lead investigator Mitch Machtay, MD, University Hospitals (UH) Case Medical Center Seidman Cancer Center (Cleveland, OH, USA; www.uhhospitals.org/seidman), enrolled 250 patients at 60 cancer centers around the United States. The US National Cancer Institute (Bethesda, MD, USA)-funded trial, led by the American College of Radiology Imaging Network (ACRIN) in collaboration with Radiation Therapy Oncology Group (RTOG), enrolled 250 patients at 60 cancer centers around the country.